Yusuf Akbaba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yusuf Akbaba has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Süleyman Göksu
Department of Chemistry, Faculty of Science, Atatürk University, 25240 Erzurum, Türkiye
7 shared publications Ertan Şahin
4 shared publicationsAkın Akıncıoğlu
Agri Ibrahim Cecen University, Central Researching Laboratory, 04200 Agri, Turkey
3 shared publications- Bunyamin Ozgeris
Erzurum Technical University
3 shared publications - Claudiu Trandafir Supuran
Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Polo Scientifico, Via U. Schiff 6, Sesto Fiorentino, Firenze, 50019, Italy
3 shared publications Süleyman Göksu
Department of Chemistry, Atatürk University, Faculty of Science, Erzurum, Turkey
3 shared publications
Latest Publications
- 30 October 2025
- Published by Duzce Universitesi Bilim ve Teknoloji Dergisi in Düzce Üniversitesi Bilim ve Teknoloji Dergisi
- Vol. 13 (4) , 1695-1718
Computational Identification of Potential Antiviral Agents Against Monkeypox Virus
This study introduces a drug repurposing approach for monkeypox virus using molecular docking and molecular dynamics (MD) simulations to screen clinically approved drugs for other diseases. Potential candidates were analyzed with AutoDock software in two categories: (1) DNA polymerase inhibitors and (2) RNA polymerase inhibitors. Docking analysis identified seven promising compounds—five DNA polymerase and two RNA polymerase inhibitors—showing strong affinity toward monkeypox targets. MD simulations further confirmed their binding stability. Among them, etravirine (−8.04 kcal/mol) and valaciclovir (−7.57 kcal/mol) exhibited the highest affinity to DNA polymerase active sites at residues ASP347 and ASP462. Moreover, emetine dihydrochloride (−7.17 kcal/mol) demonstrated the strongest binding to the catalytic site of RNA polymerase. Consequently, etravirine and emetine dihydrochloride are proposed as potential therapeutics against monkeypox. Since these compounds are already approved by the U.S. Food and Drug Administration (FDA) for other viral infections, extensive safety testing and high development costs can be avoided, making this repurposing strategy an efficient and cost-effective option for managing monkeypox infection.
- 30 October 2025
- Published by Duzce Universitesi Bilim ve Teknoloji Dergisi in Düzce Üniversitesi Bilim ve Teknoloji Dergisi
- Vol. 13 (4) , 1695-1718
Computational Identification of Potential Antiviral Agents Against Monkeypox Virus
This study introduces a drug repurposing approach for monkeypox virus using molecular docking and molecular dynamics (MD) simulations to screen clinically approved drugs for other diseases. Potential candidates were analyzed with AutoDock software in two categories: (1) DNA polymerase inhibitors and (2) RNA polymerase inhibitors. Docking analysis identified seven promising compounds—five DNA polymerase and two RNA polymerase inhibitors—showing strong affinity toward monkeypox targets. MD simulations further confirmed their binding stability. Among them, etravirine (−8.04 kcal/mol) and valaciclovir (−7.57 kcal/mol) exhibited the highest affinity to DNA polymerase active sites at residues ASP347 and ASP462. Moreover, emetine dihydrochloride (−7.17 kcal/mol) demonstrated the strongest binding to the catalytic site of RNA polymerase. Consequently, etravirine and emetine dihydrochloride are proposed as potential therapeutics against monkeypox. Since these compounds are already approved by the U.S. Food and Drug Administration (FDA) for other viral infections, extensive safety testing and high development costs can be avoided, making this repurposing strategy an efficient and cost-effective option for managing monkeypox infection.
- 4 May 2023
- Published by Wiley in ChemistrySelect
- Vol. 8 (17)
An Insight into the Asymmetric Resolution of 1‐Aminoindane Derivatives
Compounds with 1‐aminoindane motif exhibit vital biological activities in the central nervous system. Therefore, it is very important to synthesize new compounds with this moiety and to obtain them in high enantiopurity. In this study, novel substituted 1‐aminoindane derivatives were synthesized, and their asymmetric resolutions were carried out. Accordingly, the reduction of 1‐indanones with NaBH 4 , conversion of alcohols to azides via an alternative Mitsunobu reaction followed by reduction of azides afforded (±)‐1‐aminoindane hydrochloride or hydrobromide salts. Amine salts were converted into their free amines by using excess amount of Et 3 N and then in situ occurred free (±)‐amines were reacted with ( R )‐O‐acetylmandeloyl chloride to give diastereomeric mixtures. The crystallization of the diastereomeric mixtures followed by hydrolysis yielded the corresponding asymmetric amines with high enantio‐purity.
- 4 May 2023
- Published by Wiley in ChemistrySelect
- Vol. 8 (17)
An Insight into the Asymmetric Resolution of 1‐Aminoindane Derivatives
Compounds with 1‐aminoindane motif exhibit vital biological activities in the central nervous system. Therefore, it is very important to synthesize new compounds with this moiety and to obtain them in high enantiopurity. In this study, novel substituted 1‐aminoindane derivatives were synthesized, and their asymmetric resolutions were carried out. Accordingly, the reduction of 1‐indanones with NaBH 4 , conversion of alcohols to azides via an alternative Mitsunobu reaction followed by reduction of azides afforded (±)‐1‐aminoindane hydrochloride or hydrobromide salts. Amine salts were converted into their free amines by using excess amount of Et 3 N and then in situ occurred free (±)‐amines were reacted with ( R )‐O‐acetylmandeloyl chloride to give diastereomeric mixtures. The crystallization of the diastereomeric mixtures followed by hydrolysis yielded the corresponding asymmetric amines with high enantio‐purity.
- Open Access
- 15 December 2022
- Published by Erzurum Technical University in Natural Products and Biotechnology
- Vol. 2 (2) , 81-87
Biological Evaluation of Aminoindane Derivatives as Antibacterial Agents
The aminoindane ring is the most studied skeletal structure in synthetic chemistry, in the synthesis of intermediates and because it is a biologically active molecule. Bioactive properties of the aminoindane ring include antibacterial, antiviral, antiapoptotic, antipyretic, analgesic, anticonvulsant, and antiparkinsonian activities. The most important bacteria in responsibility of nosocomial infections obtained in hospitals across the world are Acinetobacter baumannii and Methicillin-resistant Staphylococcus aureus. MRSA and A. baumannii have become resistant to numerous antibiotics. The development of novel antibiotic drugs is thus urgently needed. This study as investigated at the antibacterial effects of previously synthsized compounds 8 and 9 on A. baumannii and MRSA disease microorganisms. Studies on antibacterial activity employed disc diffusion and microdilution techniques. The investigation revealed that whereas the pathogenic organisms of compounds 8 and 9 formed zones that inhibited bacterial development, no zones formed in compounds 5, 6, and 7. Compounds 8 and 9's zone diameters against A. baumannii and MRSA were estimated to be between 0.7 and 1.0 mm. The range of MIC values was 3.9025–15.625 µg/ml. These results was envisaged the conclusion that derivatives with an aminoindane ring may function as MRSA and A. baumannii antibacterial agents.
- 15 December 2022
- Published by Erzurum Technical University in Natural Products and Biotechnology
- Vol. 2 (2) , 81-87
Open AccessBiological Evaluation of Aminoindane Derivatives as Antibacterial Agents
The aminoindane ring is the most studied skeletal structure in synthetic chemistry, in the synthesis of intermediates and because it is a biologically active molecule. Bioactive properties of the aminoindane ring include antibacterial, antiviral, antiapoptotic, antipyretic, analgesic, anticonvulsant, and antiparkinsonian activities. The most important bacteria in responsibility of nosocomial infections obtained in hospitals across the world are Acinetobacter baumannii and Methicillin-resistant Staphylococcus aureus. MRSA and A. baumannii have become resistant to numerous antibiotics. The development of novel antibiotic drugs is thus urgently needed. This study as investigated at the antibacterial effects of previously synthsized compounds 8 and 9 on A. baumannii and MRSA disease microorganisms. Studies on antibacterial activity employed disc diffusion and microdilution techniques. The investigation revealed that whereas the pathogenic organisms of compounds 8 and 9 formed zones that inhibited bacterial development, no zones formed in compounds 5, 6, and 7. Compounds 8 and 9's zone diameters against A. baumannii and MRSA were estimated to be between 0.7 and 1.0 mm. The range of MIC values was 3.9025–15.625 µg/ml. These results was envisaged the conclusion that derivatives with an aminoindane ring may function as MRSA and A. baumannii antibacterial agents.
- 26 September 2022
- Published by Springer Nature in Monatshefte für Chemie - Chemical Monthly
- Vol. 153 (12) , 1251-1259
A straightforward synthesis of potentially biologically active novel urea derivatives from 1,2,3,4-tetrahydronaphthalene-2-carboxylic acids
- 26 September 2022
- Published by Springer Nature in Monatshefte für Chemie - Chemical Monthly
- Vol. 153 (12) , 1251-1259
A straightforward synthesis of potentially biologically active novel urea derivatives from 1,2,3,4-tetrahydronaphthalene-2-carboxylic acids
- Open Access
- 30 June 2022
- Published by Babes-Bolyai University Cluj-Napoca in Studia Universitatis Babeș-Bolyai Chemia
- Vol. 67 (2) , 155-173
DESIGN, SYNTHESIS, BIOLOGICAL EVALUATION, AND IN SILICO STUDY OF NOVEL UREA DERIVATIVES AS INHIBITORS OF CARBONIC ANHYDRASE AND ACETYLCHOLINE ESTERASE
This study aimed to synthesize novel unsymmetrical urea derivatives containing biologically active tryptamine and phenethylamines and investigate their inhibition effects on human carbonic anhydrase (hCA) I and II isozymes as well as acetylcholinesterase (AChE). For this purpose, five different N,N'-dialkyl urea derivatives 18-22 were synthesized from tryptamine and substituted 2-phenethylamine. According to the results of inhibition, all of the synthesized urea derivatives effectively inhibited both hCA (I - II) and AChE enzymes at micromolar concentrations. The IC50 values for these molecules were determined to be in the range of 1.214-2.281 µM for hCA-I, 0.888-2.984 µM for hCA-II, and 0.309-0.816 µM for AChE. The most potent inhibitors against hCA-I and hCA-II isozymes are compound 18 (IC50: 1.214 µM; Ki: 0.984 ± 0.277 µM) and compound 19 (IC50: 0.888 µM, Ki: 0.564 ± 0.019 µM), respectively. Furthermore, compound 20 (IC50: 0.309 M and Ki: 0.470 ± 0.039 M) is the most effective AChE inhibitor. Molecular docking studies of compounds with the most effective inhibition were performed. The estimated binding energy values for compounds 18, 19, and 20 were calculated to be −7.81, -7.34, and -8.20 kcal/mol, respectively. Finally, the ADME studies were determined these compounds' physicochemical and pharmacokinetic descriptors and drug-like properties.
- 30 June 2022
- Published by Babes-Bolyai University Cluj-Napoca in Studia Universitatis Babeș-Bolyai Chemia
- Vol. 67 (2) , 155-173
Open AccessDESIGN, SYNTHESIS, BIOLOGICAL EVALUATION, AND IN SILICO STUDY OF NOVEL UREA DERIVATIVES AS INHIBITORS OF CARBONIC ANHYDRASE AND ACETYLCHOLINE ESTERASE
This study aimed to synthesize novel unsymmetrical urea derivatives containing biologically active tryptamine and phenethylamines and investigate their inhibition effects on human carbonic anhydrase (hCA) I and II isozymes as well as acetylcholinesterase (AChE). For this purpose, five different N,N'-dialkyl urea derivatives 18-22 were synthesized from tryptamine and substituted 2-phenethylamine. According to the results of inhibition, all of the synthesized urea derivatives effectively inhibited both hCA (I - II) and AChE enzymes at micromolar concentrations. The IC50 values for these molecules were determined to be in the range of 1.214-2.281 µM for hCA-I, 0.888-2.984 µM for hCA-II, and 0.309-0.816 µM for AChE. The most potent inhibitors against hCA-I and hCA-II isozymes are compound 18 (IC50: 1.214 µM; Ki: 0.984 ± 0.277 µM) and compound 19 (IC50: 0.888 µM, Ki: 0.564 ± 0.019 µM), respectively. Furthermore, compound 20 (IC50: 0.309 M and Ki: 0.470 ± 0.039 M) is the most effective AChE inhibitor. Molecular docking studies of compounds with the most effective inhibition were performed. The estimated binding energy values for compounds 18, 19, and 20 were calculated to be −7.81, -7.34, and -8.20 kcal/mol, respectively. Finally, the ADME studies were determined these compounds' physicochemical and pharmacokinetic descriptors and drug-like properties.
- 1 June 2021
- Published by Igdir University in Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi
- Vol. 11 (2) , 1374-1384
Synthesis of Potentially Biologically Active Some Asymmetric Phenylethyl Urea Derivatives
Bu çalışmada, bir dizi potansiyel biyolojik aktif asimetrik üre türevi sentezlenmiştir. Buna göre (R)-(+)-1-feniletilamin (7) 1,1’-karbonildiimidazol ile su içerisinde reaksiyona sokulmuş ve imidazolid ara ürünleri oluşturulmuştur. Daha sonra üzerine fenetilamin (8a) ve sübstitüe fenetilamin türevleri (8b-e) verildi. Sonuç olarak, potansiyel biyolojik aktif yeni asimetrik üreler (R)-1-fenetil-3- (1-feniletil) üre (9a) ve sübstitüe türevleri (9b-e), % 60 - % 71 arasındaki verimlerle elde edildi.
- 1 June 2021
- Published by Igdir University in Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi
- Vol. 11 (2) , 1374-1384
Synthesis of Potentially Biologically Active Some Asymmetric Phenylethyl Urea Derivatives
Bu çalışmada, bir dizi potansiyel biyolojik aktif asimetrik üre türevi sentezlenmiştir. Buna göre (R)-(+)-1-feniletilamin (7) 1,1’-karbonildiimidazol ile su içerisinde reaksiyona sokulmuş ve imidazolid ara ürünleri oluşturulmuştur. Daha sonra üzerine fenetilamin (8a) ve sübstitüe fenetilamin türevleri (8b-e) verildi. Sonuç olarak, potansiyel biyolojik aktif yeni asimetrik üreler (R)-1-fenetil-3- (1-feniletil) üre (9a) ve sübstitüe türevleri (9b-e), % 60 - % 71 arasındaki verimlerle elde edildi.
- 1 August 2017
- Published by Elsevier in Archives of Medical Research
- Vol. 48 (6) , 513-519
Synthesis and Anticancer Activity of Novel Ureas and Sulfamides Incorporating 1-Aminotetralins
- 1 August 2017
- Published by Elsevier in Archives of Medical Research
- Vol. 48 (6) , 513-519
Synthesis and Anticancer Activity of Novel Ureas and Sulfamides Incorporating 1-Aminotetralins
- 1 July 2016
- Published by Elsevier in Tetrahedron: Asymmetry
- Vol. 27 (11-12) , 475-479
Synthesis and asymmetric resolution of a dopaminergic compound: 2-amino-5-methoxyindane
- 1 July 2016
- Published by Elsevier in Tetrahedron: Asymmetry
- Vol. 27 (11-12) , 475-479
Synthesis and asymmetric resolution of a dopaminergic compound: 2-amino-5-methoxyindane
- 17 March 2016
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 31 (6) , 1484-1491
Synthesis and inhibitory properties of some carbamates on carbonic anhydrase and acetylcholine esterase
A series of carbamate derivatives were synthesized and their carbonic anhydrase I and II isoenzymes and acetylcholinesterase enzyme (AChE) inhibitory effects were investigated. All carbamates were synthesized from the corresponding carboxylic acids via the Curtius reactions of the acids with diphenyl phosphoryl azide followed by addition of benzyl alcohol. The carbamates were determined to be very good inhibitors against for AChE and hCA I, and II isoenzymes. AChE inhibition was determined in the range 0.209–0.291 nM. On the other hand, tacrine, which is used in the treatment of Alzheimer’s disease possessed lower inhibition effect (Ki: 0.398 nM). Also, hCA I and II isoenzymes were effectively inhibited by the carbamates, with inhibition constants (Ki) in the range of 4.49–5.61 nM for hCA I, and 4.94–7.66 nM for hCA II, respectively. Acetazolamide, which was clinically used carbonic anhydrase (CA) inhibitor demonstrated Ki values of 281.33 nM for hCA I and 9.07 nM for hCA II. The results clearly showed that AChE and both CA isoenzymes were effectively inhibited by carbamates at the low nanomolar levels.
- 17 March 2016
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 31 (6) , 1484-1491
Synthesis and inhibitory properties of some carbamates on carbonic anhydrase and acetylcholine esterase
A series of carbamate derivatives were synthesized and their carbonic anhydrase I and II isoenzymes and acetylcholinesterase enzyme (AChE) inhibitory effects were investigated. All carbamates were synthesized from the corresponding carboxylic acids via the Curtius reactions of the acids with diphenyl phosphoryl azide followed by addition of benzyl alcohol. The carbamates were determined to be very good inhibitors against for AChE and hCA I, and II isoenzymes. AChE inhibition was determined in the range 0.209–0.291 nM. On the other hand, tacrine, which is used in the treatment of Alzheimer’s disease possessed lower inhibition effect (Ki: 0.398 nM). Also, hCA I and II isoenzymes were effectively inhibited by the carbamates, with inhibition constants (Ki) in the range of 4.49–5.61 nM for hCA I, and 4.94–7.66 nM for hCA II, respectively. Acetazolamide, which was clinically used carbonic anhydrase (CA) inhibitor demonstrated Ki values of 281.33 nM for hCA I and 9.07 nM for hCA II. The results clearly showed that AChE and both CA isoenzymes were effectively inhibited by carbamates at the low nanomolar levels.
- 1 October 2014
- Published by Elsevier in Bioorganic Chemistry
- Vol. 56, 75-82
Carbonic anhydrase inhibitory properties of novel benzylsulfamides using molecular modeling and experimental studies
- 1 October 2014
- Published by Elsevier in Bioorganic Chemistry
- Vol. 56, 75-82
Carbonic anhydrase inhibitory properties of novel benzylsulfamides using molecular modeling and experimental studies